NCT01525459 Gene Expression, Immunological Status and Metabolome in Glioma Patients Status UNKNOWN Phase N/A
NCT01502605 Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas Status TERMINATED Phase PHASE1
NCT01502280 Fluorescence-guided Surgery for Low- and High-grade Gliomas Status COMPLETED Phase PHASE3
NCT01478178 Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT01473485 ExAblate (Magnetic Resonance-guided Focused Ultrasound Surgery) Treatment of Brain Tumors Status ACTIVE_NOT_RECRUITING Phase NA
NCT01465347 Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE1/PHASE2
NCT01450826 Emend and Ondansetron Compared to Ondansetron Alone to Prevent CINV in Glioma Patients Receiving Temozolomide Status COMPLETED Phase PHASE2
NCT01403311 A Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain Status UNKNOWN Phase PHASE2
NCT01394692 Comparative Study of Intraoperative MRI-guided vs. Conventional Glioma Surgery Status COMPLETED Phase NA
NCT01351519 A Study of Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors Status TERMINATED Phase PHASE2
NCT01229644 Study of Crenolanib, a Selective and Potent Inhibitor of PDGFR, for the Treatment of Adult Gliomas Status TERMINATED Phase PHASE2
NCT01220271 A Study Combining LY2157299 With Temozolomide-based Radiochemotherapy in Patients With Newly Diagnosed Malignant Glioma Status COMPLETED Phase PHASE1/PHASE2
NCT01212731 Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study Status COMPLETED Phase N/A
NCT01182883 A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Status WITHDRAWN Phase PHASE1